![Dragan Grabulovski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dragan Grabulovski
Vorstandsvorsitzender bei Araris Biotech AG
Aktive Positionen von Dragan Grabulovski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Araris Biotech AG
![]() Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | Vorstandsvorsitzender | 04.10.2023 | - |
Vorsitzender | 31.01.2019 | - | |
Gründer | 31.01.2019 | - | |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - | |
Pureos Partners AG
![]() Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Private Equity Investor | 01.09.2021 | - |
Karriereverlauf von Dragan Grabulovski
Ehemalige bekannte Positionen von Dragan Grabulovski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Covagen AG
![]() Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | - |
Gründer | 11.11.2009 | - |
Ausbildung von Dragan Grabulovski
Swiss Federal Institute of Technology | Doctorate Degree |
Statistik
International
Schweiz | 5 |
Deutschland | 2 |
Operativ
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Covagen AG
![]() Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Health Technology |
Araris Biotech AG
![]() Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | Commercial Services |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Health Technology |
Pureos Partners AG
![]() Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Finance |
- Börse
- Insiders
- Dragan Grabulovski
- Erfahrung